RxDoctor Payments DataLook up a doctor →

Oscar Galvez, MD

Nephrology · Miami, FLNPI 1578660650

Payments from drug & device makers

$14,235,926in general payments, 2019–2025

Across 588 payments — averaging $24,211 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$5M
  • Regeneron$4.6M
  • Pfizer$1.3M
  • Sanofi US Services Inc.$1.3M
  • Johnson & Johnson$1.1M
  • GSK$412K
  • plus $390K from 11 others
$1,914in research payments, 2019–2025

Across 11 payments — averaging $173.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$1K
  • Eli Lilly$633

General payments by program year

20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Janssen Research & Development, LLC79$5,043,648
Regeneron79$4,628,863
Pfizer79$1,329,081
Sanofi US Services Inc.27$1,319,351
Johnson & Johnson20$1,113,207
GSK53$411,882
Vertex3$113,543
Novartis4$101,971
Esperion Therapeutics, Inc.118$65,973
Incyte Corporation116$56,458
Chiesi USA, Inc.1$13,000
Merck1$9,930
Astrazeneca UK Limited1$9,700
Akebia Therapeutics Inc3$8,799
Eli Lilly1$5,258
AstraZeneca2$5,243
Bayer1$20

How this compares

$14,235,926 in reported general payments places this provider in the 95th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida

Medicare billing

Part B allowed, 2024
$145,009
Medicare patients
144
Services billed
900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →